FDA panel thumbs up on Shionogi’s cefiderocol

In a 14-2 vote, the FDA’s Antimicrobial Drugs Advisory Committee backed Shionogi’s (OTCPK:SGIOY) cefiderocol for the treatment of complicated urinary tract infection.
https://seekingalpha.com/news/3506356-fda-ad-com-thumbs-shionogis-cefiderocol